House · HR 1266 · 119th Congress
Combating Illicit Xylazine Act
Summary
This bill places xylazine, a sedative used in animals, on the federal controlled substances list as a Schedule III drug. Dealers who sell it illegally face criminal penalties under existing drug laws. Veterinarians and farmers who use it legally for animals are exempt from most new requirements.
In Favor
Xylazine is increasingly mixed with fentanyl, making overdoses harder to treat and more deadly. Scheduling it as a controlled substance gives law enforcement new tools to stop illegal trafficking. Legitimate animal care is protected, so farmers and vets can still use it safely.
Against
Veterinarians and animal businesses must register and keep new records, adding paperwork and cost. Small operations in rural areas may struggle to meet deadlines or navigate federal drug rules. Tighter controls could slow access to a drug that animals genuinely need.
Additional Considerations
Purpose & Problem
Is the problem real and worth federal action?
The bill places xylazine, a drug used on animals, on the federal list of controlled substances. It targets the rise in illegal use of xylazine, often mixed with fentanyl.
Scope & Related Provisions
Does it stay focused, or carry unrelated add-ons?
The bill stays focused on controlling xylazine. It covers scheduling, tracking, penalties, registration rules, and required reports on xylazine use.
Who Is Affected
Who benefits, and who bears the cost?
Veterinarians, pharmacies, and xylazine makers face new registration and tracking duties. People who legally possess xylazine for animals are exempt from registration requirements.
Cost & Funding
Is it affordable and responsibly funded?
The bill does not authorize or appropriate a specific dollar amount. It shifts costs onto the DEA and FDA to enforce new rules, track xylazine sales, and produce required reports.
Risks & Implementation
What could go wrong in practice?
The bill sets tight deadlines, giving practitioners only 60 days to register and manufacturers one year to meet labeling rules. Meeting those timelines may be difficult for some affected groups.
For the actual bill text, see congress.gov.
AI-generated · Published 10/14/2026